Abstract
ROLE OF AYURVEDA IN THE HOLISTIC MANAGEMENT OF TYPE 2 DIABETES MELLITUS (MADHUMEHA): A SINGLE-CASE STUDY
Acharya Manish, Dr. Gitika Chaudhary*, Dr. Richa, Dr. Pawan, Dr. Tanu Rani
ABSTRACT
Type 2 Diabetes Mellitus (T2DM) is a multifactorial metabolic disorder characterized by insulin resistance, impaired insulin secretion, and chronic hyperglycemia, contributing significantly to global morbidity and mortality through microvascular and macrovascular complications. While conventional management includes lifestyle modification, pharmacotherapy, and regular monitoring, Ayurveda identifies T2DM as Madhumeha, a subtype of Prameha, primarily involving vitiated Kapha and Vata doshas with pathogenesis rooted in Agni derangement and Srotorodha. This case study evaluates the effect of Ayurvedic treatment in a 44-year-old male who presented at Jeena Sikho Lifecare Limited Hospital, Dehradun, Uttarakhand, India, with fatigue, general weakness, diabetic neuropathy, frothy urine, and burning micturition. A personalized Ayurvedic treatment plan involving Shodhana, Shamana, Ayurvedic medications, dietary changes, and lifestyle recommendations was implemented. Following treatment, the patient showed significant improvement, including a reduction in Random Blood Sugar from 265 mg/dL to 153 mg/dL, HbA1c from 9.3% to 6.4%, and average blood glucose from 220 mg/dL to 137 mg/dL. Symptomatic relief was also reported, with resolution of neuropathic and urinary symptoms. This case highlights the promising role of Ayurvedic interventions as a complementary approach to the holistic management of T2DM.
[Full Text Article] [Download Certificate]WJPLS CITATION 
| All | Since 2020 | |
| Citation | 590 | 424 |
| h-index | 12 | 10 |
| i10-index | 17 | 14 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here



